|Exchange:||American Stock Exchange|
|Stock:||Aoxing Pharmaceutical Company, Inc.|
|Industry:||Drug Manufacturers - Major|
|Aoxing Pharmaceutical Company, Inc. was incorporated in the State of Florida on January 23, 1996. The Company is engaged in developing narcotics and pain management products. Its main products include Zhongtongan- It is a capsule of herbal extraction manufactured under modern GMP standard for the indication of oral and dental pain, Bismuth Potassium Citrate- An oral solution containing bismuth subcitrate potassium, for the treatment of chronic gastritis and stomachache due to excessive stomach acid, Xiaopiling- A granule formulation of herbal extraction manufactured under modern GMP standard for the treatment of fatigue from lack of rest, and Naloxone Hydrochloride- An IV formulation for the treatment of opioid over dosage. Currently Hebei Aoxing is authorize by the SFDA to manufacture Naloxone Hydrochloride injectable in four dosage strengths- 0.4mg (1ml), 1mg (1ml), 2mg (2ml) and 4mg (10ml).|
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.